The tangential force between two particles with different equivalent diameters for P3: (a) elastic tangential contact force; (b) viscous tangential contact force. by Yongfeng Zhu (7361045)

Subjects:

ESR model estimation results of the impact of microcredit on farmers’ production and operation income. by Yin Liu (50073)

The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in high-fat diet (HFD)/ streptozotocin (STZ) -induced diabetic kidneys. by Liping Bao (2936715)

Subjects:

The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in HK-2 cells. by Liping Bao (2936715)

Subjects:

The biochemical data and protein expression levels. by Liping Bao (2936715)

Subjects:

Effects of CGA on renal biochemical markers. by Liping Bao (2936715)

Subjects:

The effects of CGA on renal histopathological injury. by Liping Bao (2936715)

Subjects:

Intervention in the CGA-induced activation of the Nrf2 pathway and its inhibition of NLRP3 inflammasome in HK-2 cells. by Liping Bao (2936715)

Subjects:

Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty. by Rahul H. Jayaram (21463899)

Subjects:

Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA. by Rahul H. Jayaram (21463899)

Subjects:

Total team A match head impacts by header scenario. by Rachel S. Watson (21864061)

Subjects:

Total team A practice head impacts by header scenario. by Rachel S. Watson (21864061)

Subjects:

Impact of B₄C & Fly ash on the Density of AMCs. by Charles Sarala Rubi (21608723)

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Study-related adverse events. by Benjamin R. Lewis (22279166)

Subjects:

Study flow chart. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects: